First-line PD-1/VEGF bispecific antibody plus chemotherapy in triple-negative breast cancer: a phase 2 trial. (nature.com)

Authors: Shao X … Ouyang Q Journal: Nature Medicine Published: 2026-08-12 DOI: https://doi.org/10.1038/s41591-026-04564-7